Glaukos Gross Margin 2014-2024 | GKOS
Current and historical gross margin for Glaukos (GKOS) over the last 10 years. The current gross profit margin for Glaukos as of September 30, 2024 is %.
| Glaukos Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.36B | $0.28B | 76.18% |
| 2024-06-30 | $0.34B | $0.26B | 76.32% |
| 2024-03-31 | $0.33B | $0.25B | 76.07% |
| 2023-12-31 | $0.31B | $0.24B | 76.11% |
| 2023-09-30 | $0.30B | $0.23B | 75.91% |
| 2023-06-30 | $0.30B | $0.22B | 75.68% |
| 2023-03-31 | $0.29B | $0.22B | 75.78% |
| 2022-12-31 | $0.28B | $0.21B | 75.62% |
| 2022-09-30 | $0.29B | $0.22B | 75.79% |
| 2022-06-30 | $0.29B | $0.22B | 76.47% |
| 2022-03-31 | $0.29B | $0.23B | 76.87% |
| 2021-12-31 | $0.29B | $0.23B | 76.87% |
| 2021-09-30 | $0.29B | $0.22B | 76.19% |
| 2021-06-30 | $0.28B | $0.21B | 74.65% |
| 2021-03-31 | $0.24B | $0.16B | 68.07% |
| 2020-12-31 | $0.23B | $0.13B | 59.56% |
| 2020-09-30 | $0.22B | $0.13B | 59.63% |
| 2020-06-30 | $0.21B | $0.13B | 63.21% |
| 2020-03-31 | $0.24B | $0.18B | 73.22% |
| 2019-12-31 | $0.24B | $0.20B | 83.61% |
| 2019-09-30 | $0.23B | $0.20B | 86.73% |
| 2019-06-30 | $0.21B | $0.18B | 86.73% |
| 2019-03-31 | $0.20B | $0.17B | 86.67% |
| 2018-12-31 | $0.18B | $0.16B | 86.19% |
| 2018-09-30 | $0.17B | $0.15B | 86.39% |
| 2018-06-30 | $0.17B | $0.14B | 86.67% |
| 2018-03-31 | $0.16B | $0.14B | 87.12% |
| 2017-12-31 | $0.16B | $0.14B | 87.42% |
| 2017-09-30 | $0.15B | $0.13B | 86.67% |
| 2017-06-30 | $0.14B | $0.12B | 86.43% |
| 2017-03-31 | $0.13B | $0.11B | 85.16% |
| 2016-12-31 | $0.12B | $0.10B | 85.22% |
| 2016-09-30 | $0.10B | $0.09B | 85.29% |
| 2016-06-30 | $0.09B | $0.08B | 84.62% |
| 2016-03-31 | $0.08B | $0.07B | 83.75% |
| 2015-12-31 | $0.07B | $0.06B | 81.94% |
| 2015-09-30 | $0.07B | $0.05B | 77.27% |
| 2015-06-30 | $0.06B | $0.05B | 76.27% |
| 2015-03-31 | $0.05B | $0.04B | 76.92% |
| 2014-12-31 | $0.05B | $0.03B | 75.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.829B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.781B | 26.81 |
| Intuitive Surgical (ISRG) | United States | $217.430B | 113.68 |
| Alcon (ALC) | Switzerland | $43.790B | 29.30 |
| Edwards Lifesciences (EW) | United States | $40.720B | 25.86 |
| IQVIA Holdings (IQV) | United States | $37.284B | 20.54 |
| IDEXX Laboratories (IDXX) | United States | $35.259B | 41.52 |
| DexCom (DXCM) | United States | $34.017B | 51.23 |
| Waters (WAT) | United States | $24.246B | 35.85 |
| STERIS (STE) | Ireland | $21.575B | 24.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.893B | 0.00 |
| Hologic (HOLX) | United States | $16.069B | 17.45 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.597B | 13.96 |
| Globus Medical (GMED) | United States | $12.707B | 32.18 |
| Sysmex ADR (SSMXY) | Japan | $11.852B | 37.16 |
| Penumbra (PEN) | United States | $10.587B | 103.70 |
| Masimo (MASI) | United States | $9.271B | 44.86 |
| Teleflex (TFX) | United States | $8.395B | 13.39 |
| Integer Holdings (ITGR) | United States | $4.744B | 26.89 |
| Inari Medical (NARI) | United States | $4.650B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.570B | 0.00 |
| Veracyte (VCYT) | United States | $3.336B | 100.12 |
| LivaNova (LIVN) | United Kingdom | $2.642B | 15.25 |
| Nihon Kohden (NHNKY) | Japan | $2.325B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.299B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.235B | 20.10 |
| TransMedics (TMDX) | United States | $2.080B | 65.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.918B | 10.02 |
| Alphatec Holdings (ATEC) | United States | $1.614B | 0.00 |
| Artivion (AORT) | United States | $1.290B | 85.50 |
| RxSight (RXST) | United States | $1.286B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.979B | 0.00 |
| AxoGen (AXGN) | United States | $0.831B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.787B | 18.55 |
| IRadimed (IRMD) | United States | $0.752B | 40.63 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.729B | 12.39 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.657B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.587B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.576B | 30.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.496B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.494B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.488B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.486B | 0.00 |
| NeuroPace (NPCE) | United States | $0.419B | 0.00 |
| CVRx (CVRX) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.417B | 22.57 |
| Alpha Tau Medical (DRTS) | Israel | $0.279B | 0.00 |
| Inogen (INGN) | United States | $0.258B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.120B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.115B | 12.26 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| 908 Devices (MASS) | United States | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.084B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.076B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Neuronetics (STIM) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| Lucid Diagnostics (LUCD) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |